Celgene well they appear to be a very indecsive company where Mesoblast is concerned....Celgene are more involved with Juno and bluebird in the CAR T cell therapy business
Well Celgene did ask for an extension of the option and they asked for an extension of the scope of the applications. So I don't think that's indecisive.
They could have wanted them for less than MSB is prepared to let them go for.
Or a third party bidding war.
But I am posting about the upside as it's a sadly neglected area...so many shorters onto MSB it's sad.
My view for what it's worth, page-9
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |